May 2009
by David V. Sheehan, MD, MBA; Harry A. Croft, MD; E. Roderich Gossen, PhD; Randy J. Levitt, PhD; Claire Brullé, MD; Sylvie Bouchard, MD, PhD; Anna Rozova, MSc, MD
Dr. Sheehan is Distinguished University Health Professor, Professor of Psychiatry, Director, Depression and Anxiety Disorders Research Institute, University of South Florida College of Medicine, Tampa, Florida; Dr. Croft is Medical Director, San Antonio Psychiatric Research Center, San Antonio, Texas; Drs. Gossen, Levitt, Brullé, and Rozova are from Labopharm Inc., Laval, Québec, Canada; and Dr. Bouchard is from Lakeshore General Hospital, Montréal, Québec, Canada.
This is protected content.
Popularity: 9% [?]
Related posts
- Tramadol: Seizures, Serotonin Syndrome, and Coadministered Antidepressants
- Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning
- Generic Penetration in the Retail Antidepressant Market
- Real-World Data on SSRI Antidepressant Side Effects
- Warfarin and Antidepressants: Happiness without Hemorrhaging
- Use of Benzodiazepines in the Treatment of Anxiety
- Antidepressant Prescribing by Specialty and Treatment of Premenstrual Dysphoric Disorder
- Treatment of Schizoaffective Disorder
Posted in Original Research | 1 Comment »
September 29th, 2009 at 7:14 pm
This has been an informative read for me, as of presently I’m furthering my education in the MMHC program and I find these articles to be very informative and helpful towards completing my degree with a stronger understanding of issues that occur.